Literature DB >> 16240401

Tumor microenvironment: what can effusions teach us?

Jareer Kassis1, Julius Klominek, Elise C Kohn.   

Abstract

Malignant effusions, which are composed of malignant pleural and peritoneal fluid, are an unusual manifestation of cancer and frequently portend a poor prognosis. Neoplastic cells that disseminate into cavities containing effusions are highly metastatic and possess a strong autonomous proliferative drive while concurrently being stimulatory of exudative effusions. Most effusions will respond to transient therapeutic intervention, including the obliteration of potential space via pleurodesis. Cure, however, is rare, thus making effusions a biologically, biochemically, and clinically important topic of study. The local microenvironment that supports malignant growth, invasion, and dissemination of the solid primary tumor into the vasculature is composed of activated stroma that includes scaffolding consisting of materials that promote the tumor function, and vascular structures to provide conduits for travel and nutrient delivery. Less is understood about the tumor-cell microenvironment in malignant effusions. The fluid nature of such a microenvironment when compared with the solid primary tumor may have significant implications for disease dissemination and progression. Dissecting the signaling activity and components of such microenvironments will improve our understanding and ultimately our ability to provide better patient care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240401     DOI: 10.1002/dc.20280

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  19 in total

1.  Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Authors:  Geoffrey Kim; Ben Davidson; Ryan Henning; Junbai Wang; Minshu Yu; Christina Annunziata; Thea Hetland; Elise C Kohn
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

Review 2.  Microfluidic sample preparation for diagnostic cytopathology.

Authors:  Albert J Mach; Oladunni B Adeyiga; Dino Di Carlo
Journal:  Lab Chip       Date:  2013-03-21       Impact factor: 6.799

3.  SPARC ameliorates ovarian cancer-associated inflammation.

Authors:  Neveen A Said; Ahmed A Elmarakby; John D Imig; David J Fulton; Kouros Motamed
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

4.  Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.

Authors:  Cynthia Kuk; Vathany Kulasingam; C Geeth Gunawardana; Chris R Smith; Ihor Batruch; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2008-12-01       Impact factor: 5.911

5.  Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.

Authors:  Natalie M Moss; Maria V Barbolina; Yueying Liu; Limin Sun; Hidayatullah G Munshi; M Sharon Stack
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 6.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

Review 7.  Management of Malignant Lung Entrapment, the Oncothorax.

Authors:  Roman Petrov; Charles Bakhos; Abbas E Abbas
Journal:  Thorac Surg Clin       Date:  2018-02       Impact factor: 1.750

Review 8.  Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?

Authors:  Nicola Principe; Joel Kidman; Richard A Lake; Willem Joost Lesterhuis; Anna K Nowak; Alison M McDonnell; Jonathan Chee
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

9.  Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.

Authors:  Kyung Hee Lee; Sang Woon Kim; Jae-Ryong Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-06-04

10.  Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.

Authors:  He Huang; Yujie Li; Jihong Liu; Minghui Zheng; Yanling Feng; Kunhua Hu; Yongwen Huang; Qidan Huang
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.